Dopa

30 books
AwakeningsOliver Sacks
⏱ 6h 49m

Awakenings

Oliver Sacks

1973409 pp.
Synthesis of 6-alkyl derivatives of DOPA via the trans isomers of unsaturated azlactonesAbraham Pieter Morgenstern
⏱ 1h 23m

Synthesis of 6-alkyl derivatives of DOPA via the trans isomers of unsaturated azlactones

Abraham Pieter Morgenstern

196983 pp.
L-DOPA and behaviorSidney Malitz
⏱ 2h 24m

L-DOPA and behavior

Sidney Malitz

1972144 pp.
Catecholamine turnover in central nervous systemTorgny Persson
⏱ 57m

Catecholamine turnover in central nervous system

Torgny Persson

197057 pp.
Deprenyl in Parkinson's diseaseUnknown Author
⏱ 26m

Deprenyl in Parkinson's disease

Unknown Author

198826 pp.
The Clinical uses of LevodopaUnknown Author
⏱ 2h 37m

The Clinical uses of Levodopa

Unknown Author

1975157 pp.
Catechol derivatives in the skin of young miceLennart Cegrell

Catechol derivatives in the skin of young mice

Lennart Cegrell

1967No page data
Current concepts in the treatment of ParkinsonismUnknown Author
⏱ 4h 17m

Current concepts in the treatment of Parkinsonism

Unknown Author

1974257 pp.
Cardiovascular and renal effects of L-DopaT. Budya Tjandramaga
⏱ 2h 24m

Cardiovascular and renal effects of L-Dopa

T. Budya Tjandramaga

1975144 pp.
The interactions of cholinergic and anticholinergic drugs with nigro-neostriatal dopaminergic neuronsRobyn G. Young
⏱ 55m

The interactions of cholinergic and anticholinergic drugs with nigro-neostriatal dopaminergic neurons

Robyn G. Young

197755 pp.
Biosynthetic studies on the chromophore of pseudobactin from Pseudomonas fluorescens B10Brian Nowak-Thompson
⏱ 1h 13m

Biosynthetic studies on the chromophore of pseudobactin from Pseudomonas fluorescens B10

Brian Nowak-Thompson

199373 pp.
Developments in treatment for Parkinson's diseaseGeorge C. Cotzias
⏱ 1h 31m

Developments in treatment for Parkinson's disease

George C. Cotzias

197191 pp.
The Clinical Uses of L-DopaG. Stern
⏱ 2h 37m

The Clinical Uses of L-Dopa

G. Stern

1975157 pp.
Neurobiology of DOPA as a neurotransmitterYoshimi Misu
⏱ 6h 36m

Neurobiology of DOPA as a neurotransmitter

Yoshimi Misu

2005396 pp.
L-Dopa and ParkinsonismManuel Riklan
⏱ 6h 42m

L-Dopa and Parkinsonism

Manuel Riklan

1973402 pp.
Effects of feeding chicks high and low levels of tyrosine and dopa on toxicity and growth performanceJudith Jourdain-Poitevien
⏱ 50m

Effects of feeding chicks high and low levels of tyrosine and dopa on toxicity and growth performance

Judith Jourdain-Poitevien

199350 pp.
Neurobiology of DOPA as a neurotransmitterUnknown Author
⏱ 6h 24m

Neurobiology of DOPA as a neurotransmitter

Unknown Author

2006384 pp.
YeḳitsotOliver Sacks
⏱ 4h 58m

Yeḳitsot

Oliver Sacks

1990298 pp.
The Treatment of Parkinsonism with L-DopaMarks, John
⏱ 2h 45m

The Treatment of Parkinsonism with L-Dopa

Marks, John

1974165 pp.
Catechol- and indolamines in some endocrine cell systemsHans Tjälve
⏱ 2h 2m

Catechol- and indolamines in some endocrine cell systems

Hans Tjälve

1971122 pp.
Page 1 of 2Next →